Myopathies Treatment & Management

1. Angelini C. Spectrum of metabolic myopathies. Biochim Biophys Acta. 2015 Apr. 1852(4):615-21. [QxMD MEDLINE Link].

2. Nance JR, Dowling JJ, Gibbs EM, Bonnemann CG. Congenital myopathies: an update. Curr Neurol Neurosci Rep. 2012 Apr. 12(2):165-74. [QxMD MEDLINE Link].

3. Plate AM, Boyle BA. Musculoskeletal manifestations of HIV infection. AIDS Read. 2003 Feb. 13(2):62, 69-70, 72, 76. [QxMD MEDLINE Link].

4. Finsterer J, Scorza FA. SARS-CoV-2 myopathy [letter]. J Med Virol. 2021 Apr. 93 (4):1852-3. [QxMD MEDLINE Link]. [Full Text].

5. Hejbøl EK, Harbo T, Agergaard J, et al. Myopathy as a cause of fatigue in long-term post-COVID-19 symptoms: Evidence of skeletal muscle histopathology. Eur J Neurol. 2022 Jun 6. [QxMD MEDLINE Link]. [Full Text].

6. Pires RE, Reis IGN, Waldolato GS, Pires DD, Bidolegui F, Giordano V. What do we need to know about musculoskeletal manifestations of COVID-19?: a systematic review. JBJS Rev. 2022 Jun 1. 10 (6):[QxMD MEDLINE Link].

7. Valiyil R, Christopher-Stine L. Drug-related myopathies of which the clinician should be aware. Curr Rheumatol Rep. 2010 Jun. 12(3):213-20. [QxMD MEDLINE Link]. [Full Text].

8. Mangravite LM, Engelhardt BE, Medina MW, et al. A statin-dependent QTL for GATM expression is associated with statin-induced myopathy. Nature. 2013 Oct 17. 502(7471):377-80. [QxMD MEDLINE Link].

9. Muntean DM, Thompson PD, Catapano AL, et al. Statin-associated myopathy and the quest for biomarkers: can we effectively predict statin-associated muscle symptoms?. Drug Discov Today. 2017 Jan. 22(1):85-96. [QxMD MEDLINE Link].

10. Elston MS, Orr-Walker BJ, Dissanayake AM, Conaglen JV. Thyrotoxic, hypokalaemic periodic paralysis: Polynesians, an ethnic group at risk. Intern Med J. 2007 May. 37(5):303-7. [QxMD MEDLINE Link].

11. Wortmann RL. Lipid-lowering agents and myopathy. Curr Opin Rheumatol. 2002 Nov. 14(6):643-7. [QxMD MEDLINE Link].

12. Kuncl RW. Agents and mechanisms of toxic myopathy. Curr Opin Neurol. 2009 Oct. 22(5):506-15. [QxMD MEDLINE Link].

13. Berent T, Berent R, Steiner S, Sinzinger H. Statin-induced muscular side effects at rest and exercise - An anatomical mapping. Atheroscler Suppl. 2019 Dec. 40:73-8. [QxMD MEDLINE Link].

14. To F, Parker MJS, Ventín-Rodríguez C, Lilleker JB, Chinoy H. Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria. Rheumatology (Oxford). 2019 Dec 1. 58 (12):2331-3. [QxMD MEDLINE Link]. [Full Text].

15. Carstens PO, Schmidt J. Diagnosis, pathogenesis and treatment of myositis: recent advances. Clin Exp Immunol. 2014 Mar. 175(3):349-58. [QxMD MEDLINE Link].

16. Tansley SL, McHugh NJ. Serological subsets of juvenile idiopathic inflammatory myopathies--an update. Expert Rev Clin Immunol. 2016. 12(4):427-37. [QxMD MEDLINE Link].

17. Babu S, Li Y. Statin induced necrotizing autoimmune myopathy. J Neurol Sci. 2015 Apr 15. 351(1-2):13-7. [QxMD MEDLINE Link].

18. Isfort M, McVerry BJ, Shutter L, Kim M, Lacomis D. Perceived utility of electrodiagnostic testing in critical illness myopathy and polyneuropathy: A survey of intensive care unit providers. Muscle Nerve. 2022 Jul. 66 (1):90-5. [QxMD MEDLINE Link].

19. Cherin P, Belizna C, Cartry O, et al. Long-term subcutaneous immunoglobulin use in inflammatory myopathies: A retrospective review of 19 cases. Autoimmun Rev. 2016 Mar. 15(3):281-6. [QxMD MEDLINE Link].

20. Mathevon L, Michel F, Decavel P, Fernandez B, Parratte B, Calmels P. Muscle structure and stiffness assessment after botulinum toxin type A injection. A systematic review. Ann Phys Rehabil Med. 2015 Dec. 58(6):343-50. [QxMD MEDLINE Link].

21. Allen DG, Whitehead NP, Froehner SC. Absence of dystrophin disrupts skeletal muscle signaling: roles of Ca2+, reactive oxygen species, and nitric oxide in the development of muscular dystrophy. Physiol Rev. 2016 Jan. 96(1):253-305. [QxMD MEDLINE Link].

22. Fischer S, Julius U. Management of patients with statin intolerance. Atheroscler Suppl. 2017 Nov. 30:33-7. [QxMD MEDLINE Link].

23. Statland JM, Fontaine B, Hanna MG, et al. Review of the diagnosis and treatment of periodic paralysis. Muscle Nerve. 2017 Nov 10. [QxMD MEDLINE Link].

24. Lee TW, Bae E, Hwang K, et al. Severe hypokalemic paralysis and rhabdomyolysis occurring after binge eating in a young bodybuilder: Case report. Medicine (Baltimore). 2017 Oct. 96(40):e8251. [QxMD MEDLINE Link].

25. Patel K, McCoy JV, Davis PM. Recognizing thyrotoxic hypokalemic periodic paralysis. JAAPA. 2018 Jan. 31(1):31-4. [QxMD MEDLINE Link].

Courtney A Bethel, MD, MPH Clinical Assistant Professor of Emergency Medicine, Drexel University College of Medicine; Attending Physician, Department of Emergency Medicine, Mercy Fitzgerald Hospital, Trinity Health Mid-Atlantic

Courtney A Bethel, MD, MPH is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Paul Blackburn, DO, FACOEP, FACEP Attending Physician, Department of Emergency Medicine, Maricopa Medical Center

Paul Blackburn, DO, FACOEP, FACEP is a member of the following medical societies: American College of Emergency Physicians, Arizona Medical Association, American College of Osteopathic Emergency Physicians, American Medical Association

Disclosure: Nothing to disclose.

Barry E Brenner, MD, PhD, FACEP Program Director, Emergency Medicine, Einstein Medical Center Montgomery

Barry E Brenner, MD, PhD, FACEP is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Chest Physicians, American College of Emergency Physicians, American College of Physicians, American Heart Association, American Thoracic Society, New York Academy of Medicine, New York Academy of Sciences, Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article